| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00240-010-0262-9 |
| P698 | PubMed publication ID | 20224931 |
| P2093 | author name string | Michael Liebman | |
| Joseph Okombo | |||
| P2860 | cites work | Characterization and heterologous expression of the oxalyl coenzyme A decarboxylase gene from Bifidobacterium lactis | Q33206421 |
| A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating | Q33434046 | ||
| Use of a probiotic to decrease enteric hyperoxaluria | Q33989387 | ||
| Probiotics: an overview of beneficial effects. | Q34153371 | ||
| Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate | Q34205447 | ||
| Oxalate content of foods and its effect on humans | Q34396021 | ||
| Hyperoxaluria and intestinal disease. The role of steatorrhea and dietary calcium in regulating intestinal oxalate absorption | Q34430990 | ||
| Why should gastroenterologists know about fibromyalgia? Common pathogenesis and clinical implications | Q34588730 | ||
| The impact of dietary oxalate on kidney stone formation. | Q35819439 | ||
| Intestinal transport of an obdurate anion: oxalate | Q35964184 | ||
| Oxalate degradation by gastrointestinal bacteria from humans | Q36492628 | ||
| Oxalobacter formigenes gen. nov., sp. nov.: oxalate-degrading anaerobes that inhabit the gastrointestinal tract | Q36495169 | ||
| Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones. | Q36677659 | ||
| Intestinal and renal handling of oxalate loads in normal individuals and stone formers. | Q37088365 | ||
| Health and nutritional benefits from lactic acid bacteria | Q38019938 | ||
| Alterations in intestinal transport of oxalate in disease states. | Q38467481 | ||
| Intestinal excretion of oxalate in chronic renal failure | Q38467657 | ||
| Characteristics of the transport of oxalate and other ions across rabbit proximal colon | Q38469603 | ||
| Oxalobacter formigenes and its potential role in human health. | Q39640207 | ||
| Dietary oxalate and its intestinal absorption. | Q41120195 | ||
| Mechanism of stone formation | Q41361953 | ||
| Transcriptional and functional analysis of oxalyl-coenzyme A (CoA) decarboxylase and formyl-CoA transferase genes from Lactobacillus acidophilus | Q43234761 | ||
| Contribution of dietary oxalate to urinary oxalate excretion | Q43514437 | ||
| Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration | Q43725743 | ||
| Reference range for gastrointestinal oxalate absorption measured with a standardized [13C2]oxalate absorption test | Q44288987 | ||
| The urinary response to an oral oxalate load in recurrent calcium stone formers | Q44456782 | ||
| Evidence for Excessive Absorption of Oxalate by the Colon in Enteric Hyperoxaluria | Q44648483 | ||
| Oxalate degradation by intestinal lactic acid bacteria in dogs and cats | Q44955999 | ||
| Oxalate absorption and endogenous oxalate synthesis from ascorbate in calcium oxalate stone formers and non-stone formers | Q45159339 | ||
| Importance of the colon in enteric hyperoxaluria | Q45280411 | ||
| Dietary oxalate loads and renal oxalate handling | Q46644830 | ||
| Oxalate consumption by lactobacilli: evaluation of oxalyl-CoA decarboxylase and formyl-CoA transferase activity in Lactobacillus acidophilus | Q46937606 | ||
| Effect of oxalate test dose size on absolute and percent oxalate absorption | Q46962868 | ||
| Energy conservation in the decarboxylation of dicarboxylic acids by fermenting bacteria | Q47768451 | ||
| Renal stone epidemiology: A 25-year study in Rochester, Minnesota | Q50536768 | ||
| Effect of cinnamon and turmeric on urinary oxalate excretion, plasma lipids, and plasma glucose in healthy subjects. | Q51448301 | ||
| Rapid enzymatic determination of urinary oxalate. | Q52513370 | ||
| Simple, rapid, kinetic method for serum creatinine measurement | Q52964277 | ||
| Absorption kinetics of oxalate from oxalate-rich food in man. | Q55062613 | ||
| PCR detection of Bifidobacterium strains and Streptococcus thermophilus in feces of human subjects after oral bacteriotherapy and yogurt consumption | Q57004267 | ||
| Microorganisms and calcium oxalate stone disease | Q57222745 | ||
| A Randomized, Controlled Trial of Lactic Acid Bacteria for Idiopathic Hyperoxaluria | Q58118210 | ||
| VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis | Q59120549 | ||
| Intestinal Oxalate Absorption | Q69813482 | ||
| Reduction of oxalate content of foods by the oxalate degrading bacterium, Eubacterium lentum WYH-1 | Q71116678 | ||
| The cause of idiopathic calcium stone disease: hypercalciuria or hyperoxaluria? | Q71311137 | ||
| Oxalate-degrading Enterococcus faecalis | Q73837443 | ||
| Low calcium diet in hypercalciuric calcium nephrolithiasis: first do no harm | Q77546835 | ||
| Lactobacillus gasseri Gasser AM63(T) degrades oxalate in a multistage continuous culture simulator of the human colonic microbiota | Q80345059 | ||
| P433 | issue | 3 | |
| P921 | main subject | probiotics | Q1816730 |
| P304 | page(s) | 169-178 | |
| P577 | publication date | 2010-03-12 | |
| P1433 | published in | Urological Research | Q15746542 |
| P1476 | title | Probiotic-induced reduction of gastrointestinal oxalate absorption in healthy subjects | |
| P478 | volume | 38 |
| Q84848141 | Acute probiotic ingestion reduces gastrointestinal oxalate absorption in healthy subjects |
| Q36239614 | Bifidobacterium animalis subsp. lactis decreases urinary oxalate excretion in a mouse model of primary hyperoxaluria |
| Q89861538 | Calcium Oxalate Nephrolithiasis and Gut Microbiota: Not just a Gut-Kidney Axis. A Nutritional Perspective |
| Q55668670 | Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Soc |
| Q34075016 | Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Soc |
| Q33645350 | Dietary hyperoxaluria is not reduced by treatment with lactic acid bacteria |
| Q57113492 | Intestinal permeability in subjects from two different race groups with diverse stone-risk profiles |
| Q35044588 | Manipulating the gut microbiota to maintain health and treat disease |
| Q26865804 | Nephropathy in dietary hyperoxaluria: A potentially preventable acute or chronic kidney disease |
| Q36307532 | Oxalate nephropathy in systemic sclerosis: Case series and review of the literature |
| Q33624952 | Oxalate-degrading activity in Bifidobacterium animalis subsp. lactis: impact of acidic conditions on the transcriptional levels of the oxalyl coenzyme A (CoA) decarboxylase and formyl-CoA transferase genes |
| Q42816596 | Probiotics and dietary manipulations in calcium oxalate nephrolithiasis: two sides of the same coin? |
| Q34955083 | Probiotics and other key determinants of dietary oxalate absorption |
| Q90149437 | Reducing urinary oxalate by simultaneous using Sankol herbal drop with oxalate-degrading bacteria |
| Q55647915 | Screening of indigenous oxalate degrading lactic acid bacteria from human faeces and South Indian fermented foods: assessment of probiotic potential. |
| Q41689731 | The Induction of Oxalate Metabolism In Vivo Is More Effective with Functional Microbial Communities than with Functional Microbial Species |
| Q35544680 | The microbiome of the urinary tract--a role beyond infection |
Search more.